How a Single Workout Affects Gut Bugs in Women With Different Fitness Levels and Body Types
FITGut-W
The Acute Effects of an Endurance Exercise Bout the Gut Microbiome and Gut-derived Metabolome in Women's Distinct Fitness and Body Mass Indexes
1 other identifier
interventional
40
1 country
1
Brief Summary
This study aims to elucidate the differences in the gut microbiome functional activity and metabolome in adult premenopausal women with distinctive fitness levels and BMIs (with obesity, w/o obesity). The specific aims are as follows:
- Aim 1: To examine the effects of acute aerobic exercise at 60-70% heart rate reserve (HRRmax) for 30 minutes bout on changes in the abundance of SCFA-producing bacteria and their functional downstream metabolic activity.
- Aim 2: To examine the effects of acute aerobic exercise at 60-70% HRRmax 30-minute bout on changes in GM-released SCFA concentrations in stool and plasmatic metabolome.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 16, 2024
CompletedFirst Submitted
Initial submission to the registry
November 12, 2024
CompletedFirst Posted
Study publicly available on registry
November 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
October 16, 2027
July 24, 2025
July 1, 2025
2.6 years
November 12, 2024
July 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Gut Microbiome Composition
Shotgun metagenomics will be used to examine the abundance of specific SCFA-producing bacteria in the stool (e.g., Ruminococcus)
Before the exercise intervention and immediately after the intervention
Gut Microbiome Function
Shotgun metagenomics will be used to examine the BGCs (i.e., the genes within the microbial genome that dictate gut microbial functionality) to investigate functional downstream metabolic activity.
Before the exercise intervention and immediately after the intervention
Plasma Metabolome
Gas chromatography and mass spectrometry will be used to measure concentrations of SCFAs in plasma before and after the exercise intervention
Before the exercise intervention, immediately after the exercise intervention, and 24 hours before the intervention
Stool Metabolome
Gas chromatography and mass spectrometry will be used to measure concentrations of SCFAs in stool before and after the exercise intervention
Before the exercise intervention, immediately after the exercise intervention, and 24 hours before the intervention
Study Arms (1)
Intervention
EXPERIMENTAL30-minute exercise bout in a cycle ergometer at 60 to 70% of the Heart Rate Reserve (HRR) and corresponding power (watts).
Interventions
30-minute exercise bout in a cycle ergometer at 60 to 70% of the Heart Rate Reserve (HRR) and corresponding power (watts).
Eligibility Criteria
You may qualify if:
- Biological sex: female
- BMI 19 to 24.99 kg/m2 or BMI 30-40 kg/m2
- Exercisers: Exercise at least 4 times per week for 60 minutes (a total of 240 minutes per week) on a programmed exercise training either on endurance sports (e.g., running, cycling, triathlon), strength (e.g., powerlifting), or team sports (e.g., rugby, football, soccer)
- Non-Exercisers: Sedentary individuals who have not reached the PA guidelines (150 minutes of moderate-intensity physical activity a week, 75 minutes of vigorous-intensity physical activity, or an equivalent combination of moderate and vigorous-intensity physical activity).
You may not qualify if:
- Biological sex: male
- BMI \< 19 kg/m2 or \> 40 kg/m2
- Currently pregnant, \< 2 years postpartum, lactating
- Currently taking any herbal, fiber, or prebiotic supplement
- Current or 1-month before the study, taking oral or vaginal antibiotics
- Diagnosed with any gastrointestinal, endocrine, digestive, cancer, or cardiovascular disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Milken Institute School of Public Health, The George Washington University
Washington D.C., District of Columbia, 20037, United States
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 12, 2024
First Posted
November 15, 2024
Study Start
October 16, 2024
Primary Completion (Estimated)
June 1, 2027
Study Completion (Estimated)
October 16, 2027
Last Updated
July 24, 2025
Record last verified: 2025-07
Data Sharing
- IPD Sharing
- Will not share
We will not be sharing individual participant data (IPD) for this study. Protecting participant privacy is a priority; even de-identified data carries a risk of re-identification, particularly in a smaller sample.